ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

SLRX Salarius Pharmaceuticals Inc

2.92
-0.56 (-16.09%)
Jun 18 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Salarius Pharmaceuticals Inc SLRX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.56 -16.09% 2.92 18:57:43
Open Price Low Price High Price Close Price Previous Close
3.57 2.54 3.88 2.9882 3.48
more quote information »

Recent News

Date Time Source Heading
6/17/202407:11EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
6/17/202407:05EDGAR2Form 8-K - Current report
6/17/202407:00GLOBEClinical Data on Salarius Pharmaceuticals’ Seclidemstat in..
6/14/202415:04EDGAR2Form 8-K - Current report
6/12/202407:00GLOBESalarius Pharmaceuticals Announces 1-for-8 Reverse Stock..
5/13/202415:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
3/22/202415:05GLOBESalarius Pharmaceuticals Reports Fourth Quarter and Full..
3/06/202415:02EDGAR2Form 8-K - Current report
2/22/202415:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202415:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/22/202407:00GLOBESalarius Provides Update on Strategic Review Process and..
1/16/202407:00GLOBESalarius Pharmaceuticals Issued U.S. Patent for..
1/03/202407:30GLOBEInvestigator-initiated Phase 1/2 Clinical Trial Using..
11/09/202316:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/07/202307:30GLOBESalarius Completes FDA Type B Meeting for Seclidemstat Ewing..
10/27/202314:57EDGAR2Form SC 13D - General statement of acquisition of beneficial..
9/06/202316:09EDGAR2Form 8-K - Current report
8/10/202315:14EDGAR2Form 8-K - Current report
8/10/202315:13EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/10/202315:05GLOBESalarius Pharmaceuticals Reports Second Quarter 2023..
8/08/202315:05GLOBESalarius Pharmaceuticals Announces Plans to Explore..
7/12/202308:22EDGAR2Form 8-K - Current report
7/11/202307:30GLOBESalarius Pharmaceuticals Receives FDA Clearance of SP-3164..

Your Recent History

Delayed Upgrade Clock